/
/
/

Vanta Bioscience Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)0.00
Volume (₹)0.00
High (₹)0.00
Upper Circuit20.62
Low (₹)0.00
Lower Circuit18.66
Prev Close19.64
52W High (₹)29.00
Price19.64
52W Low (₹)14.71

Share Market Cap & Key Ratios Overview

M.Cap (₹)13.97 Cr
Div. Yield (%)0.00
PE Ratio129.33
Debt to Equity6.72
Price to Book1.34
Book Value16.51
EPS (TTM)0.15
Face Value10.00
ROE (%)-103.74

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SAGILITY-ANSE
SYNGENE-ANSE
INDGN-ANSE
IGIL-ANSE
NESCO-ANSE
JUSTDIAL-ANSE
LATENTVIEW-ANSE
CMSINFO-ANSE
MEDIASSIST-ANSE
AWFIS-ANSE
VANTABIO-MTNSE
LTP
1W Low
1W High
Market cap (₹)
46.74+0.34 (0.73%)
45.85
47.47
21,885Cr
396.5-6.9 (-1.71%)
395.10
407.50
16,169Cr
601.65+23 (3.97%)
579.95
616
14,458Cr
324.5-14.85 (-4.38%)
321.35
346.50
14,065Cr
1050.05+1.75 (0.17%)
1028.80
1065.90
7,366Cr
692.95-11.7 (-1.66%)
688.90
734
5,918Cr
266.8-13.7 (-4.88%)
265.20
278.60
5,504Cr
242-0.55 (-0.23%)
238.35
253.95
3,918Cr
339.85+6.35 (1.90%)
328
348.50
2,567Cr
261.05+7.5 (2.96%)
250.95
268.70
1,835Cr
19.64+0 (0.00%)
19.64
19.64
14Cr

Key Highlights of Vanta Bioscience Ltd Balance Sheet

Vanta Bioscience Ltd balance sheet discloses shareholders' funds of ₹6.31Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹6.31Cr, and the reserves and surplus of the company is ₹10.82Cr.

The company has its non-current liabilities with total liabilities of ₹55.84Cr as of 2025-03-31.

The current liabilities are ₹18.57Cr as of 2025-03-31. At the same time, current assets are ₹10.39Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹3Cr and tangible assets of ₹42.43Cr, provided in the Vanta Bioscience Ltd financial statements.